- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 417/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 417/04
Total number of patents in this class: 4066
10-year publication summary
|
321
|
266
|
314
|
343
|
295
|
283
|
241
|
268
|
197
|
86
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4896 |
95 |
| Novartis AG | 10963 |
58 |
| Merck Sharp & Dohme LLC | 3738 |
49 |
| Bayer AG | 3288 |
48 |
| F. Hoffmann-La Roche AG | 7912 |
47 |
| Merck Patent GmbH | 5831 |
45 |
| VALO Health, Inc. | 172 |
44 |
| Boehringer Ingelheim International GmbH | 4702 |
43 |
| Janssen Pharmaceutica N.V. | 3431 |
42 |
| Vertex Pharmaceuticals Incorporated | 1589 |
42 |
| Hoffmann-La Roche Inc. | 3357 |
37 |
| Amgen Inc. | 4024 |
37 |
| Rigel Pharmaceuticals, Inc. | 542 |
35 |
| Abbvie Inc. | 1795 |
34 |
| Dana-Farber Cancer Institute, Inc. | 2545 |
34 |
| Takeda Pharmaceutical Company Limited | 2703 |
30 |
| Syngenta Participations AG | 1927 |
29 |
| Bayer Cropscience AG | 2074 |
29 |
| BASF SE | 20728 |
27 |
| Gilead Sciences, Inc. | 2018 |
27 |
| Other owners | 3234 |